Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 7276 to 7290 of 8314 results

  1. Extracorporeal membrane carbon dioxide removal (IPG428)

    Interventional procedures, IPG428 - Issued: June 2012 --> This guidance has been updated and replaced by NICE interventional procedure guidance 564.    

  2. Microwave ablation for the treatment of liver metastases (IPG406)

    Interventional procedures, IPG406 - Issued: August 2011 --> This guidance has been updated and replaced by NICE interventional procedure guidance 553.

  3. Transcatheter aortic valve implantation for aortic stenosis (IPG421)

    Interventional procedures, IPG421 - Issued: March 2012 --> This guidance has been updated and replaced by NICE interventional procedures guidance 586.

  4. Percutaneous transluminal radiofrequency sympathetic denervation of the renal artery for resistant hypertension (IPG418)

    Interventional procedures, IPG418 - Issued: January 2012 --> This guidance has been updated and replaced by NICE interventional procedures guidance 754.

  5. Focal therapy using high-intensity focused ultrasound for localised prostate cancer (IPG424)

    Interventional procedures, IPG424 - Issued: April 2012 --> This guidance has been updated and replaced by NICE interventional procedures guidance 756.

  6. Irreversible electroporation for treating pancreatic cancer (IPG442)

    Interventional procedures, IPG442 - Issued: February 2013 --> This guidance has been updated and replaced by NICE interventional procedures guidance 579.

  7. Insertion and use of implantable pulmonary artery pressure monitors in chronic heart failure (IPG463)

    Interventional procedures, IPG463 - Issued: August 2013 --> This guidance has been updated and replaced by NICE interventional procedures guidance 711.

  8. Insertion of a subcutaneous implantable cardioverter defibrillator for prevention of sudden cardiac death (IPG454)

    Interventional procedures, IPG454 - Issued: April 2013 --> This guidance has been updated and replaced by NICE interventional procedures guidance 603.

  9. Electrochemotherapy for primary basal cell carcinoma and primary squamous cell carcinoma (IPG447)

    Interventional procedures, IPG447 - Issued: March 2013 --> This guidance has been updated and replaced by NICE interventional procedures guidance 478.

  10. Sutureless aortic valve replacement for aortic stenosis (IPG456)

    Interventional procedures, IPG456 - Issued: July 2013 --> This guidance has been updated and replaced by NICE interventional procedures guidance 624.

  11. Subcutaneous implantation of a battery-powered catheter drainage system for managing refractory and recurrent ascites (IPG479)

    Interventional procedures, IPG479 - Issued: February 2014 --> This guidance has been updated and replaced by NICE interventional procedures guidance 631.

  12. Insertion of endobronchial valves for lung volume reduction in emphysema (IPG465)

    Interventional procedures, IPG465 - Issued: September 2013 --> This guidance has been updated and replaced by NICE interventional procedures guidance 600.

  13. Free fluid thermal endometrial ablation (IPG51)

    Interventional procedures, IPG51 - Issued: March 2004 --> This guidance has been withdrawn as the use of this procedure is now covered in the NICE guideline on heavy menstrual bleeding: assessment and management. NICE has no plans to carry out further assessment of this procedure under the Interventional Procedures Programme. 

  14. Transcatheter valve-in-valve implantation for aortic bioprosthetic valve dysfunction (IPG504)

    Interventional procedures, IPG504 - Issued: September 2014 --> This guidance has been updated and replaced by NICE interventional procedures guidance 653.

  15. Endovascular aneurysm sealing for abdominal aortic aneurysm (IPG547)

      March 2019: We have withdrawn the guidance because the CE mark for the Nellix Endovascular Aneurysm Sealing (EVAS) System has been withdrawn. Endologix is recalling unused stock. The MHRA recommends enhanced patient surveillance (see MDA/2019/002) because of a high risk of the graft failing beyond 2 years after implantation.